{"id":"W2062073156","doi":"10.1002/cncr.11468","title":"Fulvestrant versus anastrozole for the treatment of advanced breast carcinoma in postmenopausal women","year":2003,"lang":"en","type":"article","venue":"Cancer","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":313,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"Chugai Pharmaceutical; Genentech; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Anastrozole; Fulvestrant; Medicine; Internal medicine; Clinical endpoint; Tolerability; Oncology; Randomized controlled trial; Breast cancer; Estrogen receptor; Cancer; Tamoxifen; Adverse effect","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003845985,0.00009278113,0.00009978998,0.00001450781,0.00002934111,0.000003033342,0.00005455659,0.00006207795,0.00001202026],"category_scores_gemma":[0.000005317258,0.00006165501,0.00004386141,0.00005078471,0.00004280272,0.000001516764,0.000004395631,0.00002554052,6.310898e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006377023,"about_ca_system_score_gemma":0.00009075012,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002764483,"about_ca_topic_score_gemma":0.0000231412,"domain_scores_codex":[0.9995051,0.0000203268,0.00009287344,0.0001445946,0.0000378438,0.0001992781],"domain_scores_gemma":[0.9997329,0.00001792464,0.00003475074,0.0001509685,0.00002356516,0.00003996356],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.003852774,0.000373328,0.007067007,0.00002859175,0.0003009679,0.000006390265,0.0005406468,0.002540694,0.9396917,0.0002490333,0.0001739871,0.04517487],"study_design_scores_gemma":[0.01348311,0.0085756,0.02202364,0.00001876904,0.00008847997,0.00001922983,0.000990391,0.00009827567,0.9025397,0.00002724298,0.05184446,0.0002910623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9915493,0.007602545,0.00001703183,0.00005250081,0.0002155087,0.0003109778,0.00005145836,0.000002269209,0.0001984337],"genre_scores_gemma":[0.9985215,0.0009182586,0.00006384028,0.00001925051,0.00005308908,0.000258163,0.00001556843,0.00001132835,0.000138967],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05167048,"threshold_uncertainty_score":0.2514218,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008447864023082265,"score_gpt":0.2622407241857382,"score_spread":0.253792860162656,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}